protagonist-inc.com (PTGX) Company Sales Volume

Protagonist - graphic logo of issuer PTGX

Protagonist Therapeutics (PTGX) sales performance demonstrates a trend where 0.55 reflects the latest metric value. The optimization of peptide storage simplifies global delivery, increasing overall profitability. Business development remains independent of market cycles due to contracts with pharma behemoths. Capitalization is based on partner payments for the creation of innovative therapies for inflammatory processes and immune pathologies.

PTGX Protagonist Therapeutics, Inc.: Company Revenue in the range 07/04/2022 - 11/16/2026

Analytical breakdowns for Protagonist Therapeutics

- price and consensus price forecast:
General company analysis:Protagonist Therapeutics, PTGX
Flagship merchandise of Protagonist Therapeutics

Revenue dynamics measure the aggregate cash flow from asset realization, allowing investors to determine the fundamental value of the business and future income forecasts through trend analysis. Given the defensive profile of Protagonist Therapeutics (PTGX), where demand for peptide drugs is not subject to macroeconomic shocks, the company's sales volumes serve as a precise indicator of real market adoption of innovations.

Key competitors

Revenue and Sales Volume argenx.com|Company Revenue BioNTech Group (BNTX)|Abivax S.A. - Company Sales Volume|Revenue and Sales Volume ADMA (admabiologics.com)|Immunovant Corp (IMVT) - Company Total Revenue|KNSA - Company Revenue|Company Total Sales Volume grifols.com (GRFS)|ADPT: Revenue and Sales Volume|Company Total Revenue Celldex Therapeutics Inc (CLDX)|Company Revenue Aurinia Pharma|Company Total Revenue BioCryst Pharmaceuticals Inc BCRX|Revenue and Sales Volume VERA|Dianthus Therapeutics, Inc. - Company Sales Volume|Pharvaris - Company Sales|AbCellera Biologics Inc. - Company Revenue|Tourmaline Bio Inc - Revenue and Sales Volume|Company Total Sales Volume Intrexon (PGEN)|Pharming Group (PHAR) - Company Revenue|Nektar Therapeutics Inc. - Company Sales Revenue|Company Sales UPB|Zenas Bio (ZBIO) - Company Gross Revenue|Company Sales IMNM (Immunome Corp)|GOSS (Gossamer Corp) - Company Sales Revenue|Company Revenue KalVista Pharmaceuticals Inc KALV|Company Gross Revenue septerna.com (SEPN)|PVLA - Company Revenue|Company Gross Revenue Savara Inc SVRA|RIGL: Revenue and Sales Volume|ANAB - Company Gross Revenue|Company Revenue Astria Pharma|Company Sales Volume ENGN (enGene Holdings Inc.)|Company Sales RAPT (RAPT Therapeutics, Inc.)|Revenue and Sales Volume Aerovate Therapeutics, Inc. (JBIO)|Revenue and Sales Volume ACRS (aclaristx.com)|Kyverna Therapeutics (KYTX) - Company Total Revenue|tizianalifesciences.com - Revenue and Sales Volume|CABA (Cabaletta Bio, Inc.) - Company Sales Volume|VTYX: Revenue and Sales Volume|THTX - Company Gross Revenue|Company Revenue Avalo Therapeutics Inc|Eledon (ELDN) - Company Gross Revenue|Company Revenue agenusbio.com (AGEN)|CLYM (Climb Bio Inc) - Company Sales Revenue|Revenue and Sales Volume ZURA (zurabio.com)|Company Sales Revenue ATYR|ADAG - Company Revenue|ikenaoncology.com (IMA) - Company Sales|Shattuck Labs (STTK) - Company Revenue|EQ - Company Gross Revenue|CNTB (connectbiopharm.com) - Revenue and Sales Volume|IMUX: Company Sales Revenue|Company Revenue Atara Biotherapeutics, Inc. (ATRA)|Company Gross Revenue InflaRx NV|Revenue and Sales Volume XFOR (X4 Pharmaceuticals)|Revenue and Sales Volume Adicet Bio ACET|CELU: Company Sales|Company Sales Revenue INMB (INmune Bio)|Barinthus Bio (BRNS) - Company Revenue|Kezar Life Sciences (KZR) - Revenue and Sales Volume|Company Revenue sabbiotherapeutics.com|Revenue and Sales Volume Akari Therapeutics Plc|Company Revenue Enlivex Therapeutics Ltd (ENLV)|Q32 Bio Corp (QTTB) - Company Total Sales Volume|Company Revenue GeoVax Corp GOVX|Company Gross Revenue Edesa Biotech Corp (EDSA)|IBIO: Company Sales|Company Sales Revenue CARM (carismatx.com)|XTLB: Revenue and Sales Volume|BOLT - Company Gross Revenue|Company Sales HCWB|Company Sales Aptevo Therapeutics Inc. (APVO)|Revenue and Sales Volume AIM|ADTX: Company Annual Revenue|GRI Bio - Company Sales|Company Gross Revenue XORTX Therapeutics Inc (XRTX)|HIND: Company Sales|Revelation Biosciences (REVB) - Company Sales|Indaptus Therapeutics, Inc. (INDP) - Company Revenue|SCNI - Company Gross Revenue|CALI (CalciMedica) - Revenue and Sales Volume|Revenue and Sales Volume affimed.com|Company Revenue Allakos Therapeutics (ALLK)|HOOK - Company Total Revenue|Company Revenue IGM Biosciences, Inc. IGMS|Company Gross Revenue iTeos Therapeutics, Inc. (ITOS)|Ocean Biomedical Corp - Revenue and Sales Volume|TC BioPharm (TCBP) - Company Sales|THRD: Revenue and Sales Volume